J T

@UCLA_Alumni @UCLANsgy @UCLA Dr. Linda Liau is an American Hero !! Congratulations to her, to UCLA and to Northwest Biotherapeutics $NWBO on their recent JAMA Oncology positive peer reviewed study of the DCVax GBM Brain Cancer therapy. Most importantly, good luck to patients and their families 🙏🏼🙏🏼🙏🏼

@MichaelBoy64231 Management fails to communicate. Share price is DOWN >99% since IPO sadly. Oh well. Long term investors got fleeced.

$NWBO The stock price should be 7-10X the current price. The price is not an indication of earnings or even potential of earnings. It is not a reflection of any aspect of reality. It only reflects the co-ordinated effort to keep the price suppressed.

“May be approaching”… you’ve literally said the same thing every three months, for the past three years. 😂 . If this thing ever sees north of $1 that would be great, the majority of investors would’ve still lost their shirts over the past five and 10 years, but that’s the risk of Penny stocks. Good luck to patients and their families. 🙏🏼🙏🏼🙏🏼

$NWBO Northwest Biotherapeutics may be approaching a once in a generation inflection point after more than two decades of research and development. Their personalized immunotherapy DCVax L has completed all Phase 3 clinical trials in glioblastoma which is the most aggressive and lethal form of brain cancer with survival often measured in months. The trial demonstrated statistically meaningful life extension across all patient groups with no serious adverse safety signals reported. This represents the first meaningful improvement in GBM outcomes in decades and challenges the long standing belief that nothing can materially move the needle for this disease. I break down what the most recent UK regulatory and manufacturing updates actually mean in simple terms including why the manufacturing validation matters and why it removes the last major operational risk standing between DCVax L and commercialization. I also explain where the company currently sits in the approval process what decisions remain and what realistic timelines look like for the UK NHS NICE review European Union and United States FDA. These are not guesses but step by step explanations of how cancer therapies are approved funded and rolled out in the real world. The video also covers realistic share price scenarios tied to each milestone including approval to sell and market in the UK reimbursement decisions by NICE and subsequent EU and US approvals. I discuss why even conservative valuation models suggest a dramatic repricing if approvals occur and why potential short covering could amplify those moves but is not required for the investment thesis to succeed. This is not financial advice. It is my highest conviction and longest held investment after more than six years of continuous research interviews and tracking regulatory filings. I explain exactly what to watch for next why timing is uncertain but risk is becoming increasingly asymmetric and why the company’s recent actions speak louder than press releases. Most importantly this video explains why this story is not just about a stock but about a treatment that could meaningfully extend the lives of cancer patients around the world. 📲 JOIN MY TEXT ALERTS — Get My Daily Entries & Exits (also includes my exclusive Congressional Trade Tracker & Nancy Pelosi Tracker): 👉 itsmikepoarch.com/textalerts Promo Code: NWBO 💬 JOIN MY FREE DISCORD — Alerts, Livestreams & Classes: 👉 itsmikepoarch.com/mikesfreedisco… 💰 Grab FREE Stocks on Webull (up to $300 using this link): 👉 a.webull.com/i/AlphaStatusS… 📱 Follow Me: Instagram → instagram.com/itsmikepoarch/ TikTok → @itsmikepoarch?lang=en" target="_blank" rel="nofollow noopener">tiktok.com/@itsmikepoarch… Facebook → facebook.com/michael.poarch… Rumble → rumble.com/v6xstag-from-p…... X/Twitter → x.com/ItsMikePoarch 🔥 Topics Covered on This Channel: penny stocks, palantir, pltr stock, high growth stocks, best growth stocks, growth stocks 2025, investing in stocks, stock market investing, best stocks to buy now, 100x stocks, top stocks to buy, stock picks, stocks to watch, stock market today, stock trading strategies, swing trading, day trading, long term stocks, dividend stocks, options trading, best penny stocks, stock market news, financial education, investing for beginners, wealth building, high return stocks, stocks with massive potential, stock investing strategy, market analysis, trending stocks, investment opportunities, economic news, stock halts, congressional trades, Nancy Pelosi trades DISCLAIMER This content is for educational and informational purposes only. I am not a licensed financial advisor, registered investment advisor (RIA), or broker-dealer, and nothing in this content constitutes financial, investment, tax, or legal advice. No material shared via video, email, website, or social media constitutes a recommendation, solicitation, or endorsement to buy or sell any securities, futures, options, or other financial instruments. Trading and investing involve substantial risk and may not be suitable for everyone. You could lose some or all of your investment. Past performance is not indicative of future results. Any trading strategies, trade alerts, or examples discussed are strictly for illustration and education purposes only, and are based on personal opinion and experience. These are not trade recommendations and should not be relied upon for making investment decisions. Testimonials or user-submitted success stories may be included and represent individual experiences. These results are not verified, typical, or guaranteed. Individual outcomes vary depending on many factors, including but not limited to experience, capital, discipline, and market conditions. Affiliate links or compensation may be received in connection with some products or services mentioned. These relationships do not influence the opinions expressed or the integrity of the content. All viewers and readers are advised to conduct their own due diligence and consult with a licensed financial professional before making any financial decisions. Use of this content is at your own risk. By engaging with this material, you agree to hold the creator harmless from any financial losses or legal issues that may arise. This is a paid advertisement and is intended for informational and educational purposes only. It is a publication of Infinite Pursuit LLC, wholly owned and operated by ItsMikePoarch. Infinite Pursuit LLC is engaged in the business of marketing and advertising publicly traded companies for monetary compensation. Never invest in any stock featured in our communications unless you can afford to lose your entire investment. We are not registered investment advisors, broker-dealers, or licensed financial professionals. Nothing in this communication should be construed as personalized investment advice or a recommendation to buy or sell any security. By reading this content or interacting with our platforms, you agree to hold Infinite Pursuit LLC, ItsMikePoarch, and all associated parties harmless from any and all liability, losses, or damages that may result. Investing in micro-cap and growth securities is highly speculative and carries a high degree of risk. This communication may contain forward-looking statements, which are based on expectations, estimates, and projections as of the date of publication. Forward-looking statements involve risks and uncertainties, and actual results may differ materially. Words such as “expects,” “believes,” “projects,” “anticipates,” and similar terms identify such statements. Information provided is sourced from public data or directly from the featured company and is believed to be reliable, but no guarantee is made regarding its accuracy or completeness. This is not an offer or solicitation to buy or sell securities. We encourage all readers to conduct independent research and consult with a licensed financial advisor before investing. This communication complies with the CAN-SPAM Act of 2003. Full Terms of Use and Disclosure Policy available at: docs.google.com/document/d/1JP…

@PeterSchiff “Not your keys 🔑, not your cheese 🧀 “.

Three years and nine months ago, corrupt IRS agents convinced corrupt Puerto Rican banking regulators to put my completely solvent bank into receivership simply as a PR stunt for the J5. Since then, just a tiny fraction of the bank's customers have gotten any of their money back.

@saifedean True

Imagine what this traitor would say if an American mayor banned prayer in a synagogue in America, and compare it to this pathetic groveling.

@GovMikeHuckabee This is not “an unfortunate overreach“. This is an abomination.

My statement re Prohibiting the Latin Patriarch of entering Church of Holy Sepulcher on Palm Sunday: While all Holy sites in the Old City are closed due to safety concerns for mass gatherings including the Western Wall, Church of the Holy Sepulcher and Al Aqsa Mosque, the action today by the Israel Nat'l Police to deny Latin Patriarch Cardinal Pierbattista Pizzaballa and 3 other priests from entering the Church to offer a blessing on Palm Sunday is an unfortunate overreach already having major repercussions around the world.  Home Front Command Guidelines restrict any gatherings to 50 people or less.  The 4 representatives of the Catholic Church were well below that restriction.  Statements from the Gov't of Israel indicate the action to prohibit Cardinal Pizzaballa entry to the Church of the Holy Sepulcher were for safety reasons, but churches, synagogues, and mosques throughout Jerusalem have met with the restrictions of 50 or less.  For the Patriarch to be barred from entry to the Church on Palm Sunday for a private ceremony is difficult to understand or justify. Israel has indicated it will work with the Patriarch to accommodate a safe means of carrying out Holy Week activities.

@tedcruz This was not simply “a mistake”. This is an abomination.

Amb Huckabee is correct. This was a mistake by the Israeli police. The security concerns are real, but they should not have prevented the Patriarch from entering the Church of the Holy Sepulcher to conduct the Palm Sunday blessing. I trust this mistake will be corrected quickly.

@PeterSchiff @GrantCardone Peter, do you really think the price of gold softened because Turkey was selling?

@GrantCardone Based on what?

Bitcoin should be $280,000

@mikealfred The credit score adds little to the exercise. It would’ve been a better question without mentioning the credit score.

Imagine you had to choose your life at age 40: Option A: Single. No kids. $50M net worth. 850 credit score. Private jet. Option B: Married. 2 kids. $3M net worth. Drive a Toyota. 10 BTC in cold storage. 500 credit score. Fly Southwest. Be honest, which life are you choosing?

@DocumentingBTC 😂

NBC News reports some Christians go all in on bitcoin

@ItsMikePoarch Before we get to $50, can we get to $0.50? 😂😂😂😂😂😂😂😂😂😂

🔥 9️⃣ Short Squeeze Potential If NWBO wins the lawsuit and gets approvals... Forced buy-ins + short bans = historic short squeeze. Even a fraction of shorts covering could push the stock multiple dollars overnight. Best case? $10... $20... $50+ isn’t impossible. #shortsqueeze #MOASS

🚀 1️⃣ $NWBO — The Most Underrated Biotech Stock Nobody’s Talking About (Yet) If you care about a cure for cancer, or catching the next life-changing stock, read this entire thread. 👇

It’s easier not to eat 100 calories than it is to burn 100 calories in the gym.

@XFreeze @elonmusk @elonmusk What happened to D.O.G.E and cutting spending ?? U.S. government is now spending $2B per day in Iran 🇮🇷 war. LOL 😂

@beatrice_t31456 😂

$NWBO bought another 3000 , thanks for the cheapies

Marcus Aurelius wrote this over 1800 years ago: “When you arise in the morning think of what a privilege it is to be alive, to think, to enjoy, to love.”

@ikurx43868132 Lol. Back in December 2023, people were talking about six months to approval, 12 months to approval, 18 months to approval. Etc. etc. No one knows anything. Good luck to patients and their families. Eventually, we will find out.

$NWBO DCVax-L MAA timeline update: MAA filed/validated Dec 2023–Jan 2024. MHRA review ramps Q2 2025; CHM advisory Nov 28, 2025, effectively greenlit. Final ECA guidance & UK trial framework take effect Apr 28, 2026 — approval likely on/right after that date.

@HellasFooty Πιστολέρο! Legend

🎊 Happy 38th Birthday to Kostas Mitroglou! A real sharpshooter on his day. One of his iconic moments was this goal against Romania that sent Greece to the 2014 World Cup ⚽🇬🇷

@BattleJeff1 @TheBTCTherapist @grok @grok how often is MSTR audited to confirm BTC holdings ?

Michael Saylor moved all his BTC to Coinbase in 2023 or 2022. Nobody can verify how much he actually own anymore. He could just be announcing buying without actually buying. After all, he only need to present the BTC when MSTR holders demand it. In this sense, he is actually holding a neutral or short position. That also explained why he never run out of money. He is actually selling future BTC to MSTR holders at today's price.

Hey @Grok how is it possible Michael Saylor’s company Strategy is buying 3,000-5,000 Bitcoin a day but price isn’t moving at all. What’s actually going on…

@AlmostHeavenWV_ @TheBTCTherapist @grok Exactly

@TheBTCTherapist @grok It’s not hard. People are selling 3,000-5,000 bitcoin per day to him.

@StonkMasterJ No. But I have noticed that the share price is down more than 95% over the past decade. Is that weird? 😂

Anyone experiencing anything weird with $NWBO trading this morning? OTC website isn't updating. No trades.